Halozyme Therapeutics
(NASDAQ:HALO)
$44.48
0.48[1.09%]
At close: Jul 1
$44.48
00
After Hours: 4:30PM EDT
Day High/Low43.46 - 44.64
52 Week High/Low31.36 - 48.58
Open / Close44.03 / 44.48
Float / Outstanding117.4M / 137.9M
Vol / Avg.1.1M / 1.1M
Mkt Cap6.1B
P/E14.93
50d Avg. Price43.61
Div / Yield-
Payout Ratio-
EPS0.44
Total Float117.4M

Halozyme Therapeutics (NASDAQ:HALO), Quotes and News Summary

Halozyme Therapeutics (NASDAQ: HALO)

Day High/Low43.46 - 44.64
52 Week High/Low31.36 - 48.58
Open / Close44.03 / 44.48
Float / Outstanding117.4M / 137.9M
Vol / Avg.1.1M / 1.1M
Mkt Cap6.1B
P/E14.93
50d Avg. Price43.61
Div / Yield-
Payout Ratio-
EPS0.44
Total Float117.4M
Benzinga - May 10, 2022, 4:28PM
Benzinga - Apr 13, 2022, 10:40AM
Benzinga - Feb 2, 2022, 4:45PM
load more
Sector: Health Care.Industry: Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS0.4900.470 -0.0200
REV128.250M117.279M-10.971M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Halozyme Therapeutics Questions & Answers

Q
How do I buy Halozyme Therapeutics (HALO) stock?
A

You can purchase shares of Halozyme Therapeutics (NASDAQ: HALO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Halozyme Therapeutics's (HALO) competitors?
Q
What is the target price for Halozyme Therapeutics (HALO) stock?
A

The latest price target for Halozyme Therapeutics (NASDAQ: HALO) was reported by Goldman Sachs on Thursday, May 26, 2022. The analyst firm set a price target for 60.00 expecting HALO to rise to within 12 months (a possible 34.89% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Halozyme Therapeutics (HALO)?
A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $44.48 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Halozyme Therapeutics (HALO) pay a dividend?
A

There are no upcoming dividends for Halozyme Therapeutics.

Q
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
A

Halozyme Therapeutics’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Halozyme Therapeutics (HALO) going to split?
A

There is no upcoming split for Halozyme Therapeutics.

Q
What sector and industry does Halozyme Therapeutics (HALO) operate in?
A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.